Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQFRN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,728
Award facts
- Contract value 100% obligated
- $27,728.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,728.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). The contract, which is a non-set-aside competitive award with an ultimate completion date of June 3, 2025, represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to fulfill medical supply needs across military healthcare systems and other federal agencies. Dupixent (dupilumab) is a prescription biologic medication used to treat conditions including moderate-to-severe atopic dermatitis, asthma, and eosinophilic esophagitis. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen regularly supplies brand-name medications, generics, vaccines, and specialized medical devices to support defense and veteran healthcare operations through competitively awarded delivery orders with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DB25FQFRN?
SPE2DB25FQFRN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FQFRN worth?
The government has obligated $27,728 on SPE2DB25FQFRN.
Is contract SPE2DB25FQFRN an order under another contract?
Yes. SPE2DB25FQFRN is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQFRN competed?
The extent of competition for SPE2DB25FQFRN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award